Context Matters: the Evolving Use of Biomarkers in Alzheimer's Disease Care

Overview

Journal EBioMedicine

Specialty Biomedical Engineering

Date 2024 Oct 4

PMID 39366842

Authors

Juan Fortea

Affiliations

Soon will be listed here.

References

McGlinchey E, Duran-Aniotz C, Akinyemi R, Arshad F, Zimmer E, Cho H . Biomarkers of neurodegeneration across the Global South. Lancet Healthy Longev. 2024; 5(10):100616. PMC: 11540104. DOI: 10.1016/S2666-7568(24)00132-6. View

Fanshawe T, Power M, Graziadio S, Ordonez-Mena J, Simpson J, Allen J . Interactive visualisation for interpreting diagnostic test accuracy study results. BMJ Evid Based Med. 2018; 23(1):13-16. PMC: 5867448. DOI: 10.1136/ebmed-2017-110862. View

Karlawish J, Grill J . Alzheimer's disease biomarkers and the tyranny of treatment. EBioMedicine. 2024; 108:105291. PMC: 11663781. DOI: 10.1016/j.ebiom.2024.105291. View

Scholl M, Verberk I, Del Campo M, Delaby C, Therriault J, Chong J . Challenges in the practical implementation of blood biomarkers for Alzheimer's disease. Lancet Healthy Longev. 2024; 5(10):100630. DOI: 10.1016/j.lanhl.2024.07.013. View

Alcolea D, Beeri M, Rojas J, Gardner R, Lleo A . Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist. Neurology. 2023; 101(4):172-180. PMC: 10435056. DOI: 10.1212/WNL.0000000000207193. View

Carmona-Iragui M, OConnor A, Llibre-Guerra J, Lao P, Ashton N, Fortea J . Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome. EBioMedicine. 2024; 108:105327. PMC: 11663788. DOI: 10.1016/j.ebiom.2024.105327. View

Pascoal T, Aguzzoli C, Lussier F, Crivelli L, Suemoto C, Fortea J . Insights into the use of biomarkers in clinical trials in Alzheimer's disease. EBioMedicine. 2024; 108:105322. PMC: 11663755. DOI: 10.1016/j.ebiom.2024.105322. View

Montoliu-Gaya L, Alcolea D, Ashton N, Pegueroles J, Levin J, Bosch B . Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. EBioMedicine. 2023; 90:104547. PMC: 10070083. DOI: 10.1016/j.ebiom.2023.104547. View

Jack Jr C, Bennett D, Blennow K, Carrillo M, Feldman H, Frisoni G . A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016; 87(5):539-47. PMC: 4970664. DOI: 10.1212/WNL.0000000000002923. View

10.

McFeely A, OConnor A, Kennelly S . Use of biomarkers in the diagnosis of Alzheimer's disease in adults with intellectual disability. Lancet Healthy Longev. 2024; 5(10):100639. DOI: 10.1016/j.lanhl.2024.100639. View